Articoli di riviste sul tema "Inhibiteurs de JAK/STAT"
Cita una fonte nei formati APA, MLA, Chicago, Harvard e in molti altri stili
Vedi i top-50 articoli di riviste per l'attività di ricerca sul tema "Inhibiteurs de JAK/STAT".
Accanto a ogni fonte nell'elenco di riferimenti c'è un pulsante "Aggiungi alla bibliografia". Premilo e genereremo automaticamente la citazione bibliografica dell'opera scelta nello stile citazionale di cui hai bisogno: APA, MLA, Harvard, Chicago, Vancouver ecc.
Puoi anche scaricare il testo completo della pubblicazione scientifica nel formato .pdf e leggere online l'abstract (il sommario) dell'opera se è presente nei metadati.
Vedi gli articoli di riviste di molte aree scientifiche e compila una bibliografia corretta.
El Jammal, Thomas, Mathieu Gerfaud-Valentin, Pascal Seve e Yvan Jamilloux. "Inhibiteurs de la signalisation JAK/STAT au cours des maladies rhumatologiques : un spectre grandissant". Revue du Rhumatisme 87, n. 4 (luglio 2020): 261–72. http://dx.doi.org/10.1016/j.rhum.2020.01.032.
Sagez, F., M. Sawaf, J. Sibilia, H. Dumortier, F. Monneaux e J. E. Gottenberg. "Nouveau mécanisme d’action des inhibiteurs de la voie JAK/STAT : l’inhibition de la différenciation et de la fonction des lymphocytes T folliculaires auxiliaires". Revue du Rhumatisme 83 (novembre 2016): A215. http://dx.doi.org/10.1016/s1169-8330(16)30522-1.
Colonne, Punsiri M., Marina E. Eremeeva e Sanjeev K. Sahni. "Beta Interferon-Mediated Activation of Signal Transducer and Activator of Transcription Protein 1 Interferes with Rickettsia conorii Replication in Human Endothelial Cells". Infection and Immunity 79, n. 9 (20 giugno 2011): 3733–43. http://dx.doi.org/10.1128/iai.05008-11.
Barry, Sean P. "JAK-STAT". JAK-STAT 1, n. 2 (aprile 2012): 90–91. http://dx.doi.org/10.4161/jkst.20939.
Galli Sanchez, Ana Paula, Tatiane Ester Aidar Fernandes e Gustavo Martelli Palomino. "The JAK-STAT Pathway and the JAK Inhibitors". Journal of Clinical Research in Dermatology 7, n. 5 (30 novembre 2020): 1–6. http://dx.doi.org/10.15226/2378-1726/7/5/001128.
Minaudo, Carla. "Vía JAK-STAT e inhibidores JAK". Dermatología Argentina 28, n. 2 (1 giugno 2022): 55–62. http://dx.doi.org/10.47196/da.v28i2.2324.
Liu, Jia, Faping Wang e Fengming Luo. "The Role of JAK/STAT Pathway in Fibrotic Diseases: Molecular and Cellular Mechanisms". Biomolecules 13, n. 1 (6 gennaio 2023): 119. http://dx.doi.org/10.3390/biom13010119.
Mirault, Tristan. "Risques cardiovasculaires des inhibiteurs de JAK". JMV-Journal de Médecine Vasculaire 47 (marzo 2022): S40. http://dx.doi.org/10.1016/j.jdmv.2022.01.015.
Schieler, Jarod M., e Jeffrey O. Henderson. "Treating a Dysregulated JAK/STAT Pathway in Cancer Cells". Journal of Student Research 5, n. 1 (14 aprile 2016): 11–17. http://dx.doi.org/10.47611/jsr.v5i1.282.
Zhan, Xinliang, Yan Wang e Jing Yang. "Janus Kinase/Signal Converters, and the Transcriptional Activator Signaling Pathway Promotes Lung Cancer Through Increasing M2 Macrophage". Journal of Biomaterials and Tissue Engineering 11, n. 4 (1 aprile 2021): 605–11. http://dx.doi.org/10.1166/jbt.2021.2566.
Harrison, D. A. "The JAK/STAT Pathway". Cold Spring Harbor Perspectives in Biology 4, n. 3 (1 marzo 2012): a011205. http://dx.doi.org/10.1101/cshperspect.a011205.
Wells, William A. "A JAK/STAT invasion". Journal of Cell Biology 156, n. 3 (28 gennaio 2002): 413. http://dx.doi.org/10.1083/jcb1563rr2.
Aaronson, D. S., e C. M. Horvath. "The JAK-STAT Pathway". Science Signaling 2003, n. 197 (26 agosto 2003): cm11. http://dx.doi.org/10.1126/stke.2003.197.cm11.
Myllymäki, H., e M. Rämet. "JAK/STAT Pathway inDrosophilaImmunity". Scandinavian Journal of Immunology 79, n. 6 (21 maggio 2014): 377–85. http://dx.doi.org/10.1111/sji.12170.
Imada, Kazuroni, e Warren J. Leonard. "The Jak-STAT pathway". Molecular Immunology 37, n. 1-2 (gennaio 2000): 1–11. http://dx.doi.org/10.1016/s0161-5890(00)00018-3.
Ladyman, Sharon R., e David R. Grattan. "JAK-STAT and feeding". JAK-STAT 2, n. 2 (aprile 2013): e23675. http://dx.doi.org/10.4161/jkst.23675.
Hombría, James Castelli-Gair, e Sol Sotillos. "JAK-STAT pathway inDrosophilamorphogenesis". JAK-STAT 2, n. 3 (15 luglio 2013): e26089. http://dx.doi.org/10.4161/jkst.26089.
Mertens, Claudia, e James E. Darnell. "SnapShot: JAK-STAT Signaling". Cell 131, n. 3 (novembre 2007): 612–612. http://dx.doi.org/10.1016/j.cell.2007.10.033.
Valle-Mendiola, Arturo, Adriana Gutiérrez-Hoya e Isabel Soto-Cruz. "JAK/STAT Signaling and Cervical Cancer: From the Cell Surface to the Nucleus". Genes 14, n. 6 (24 maggio 2023): 1141. http://dx.doi.org/10.3390/genes14061141.
Rodriguez, Irasema, e Kate J. F. Carnevale. "Systematic Review: JAK-STAT Regulation and Its Impact on Inflammation Response in ARDS from COVID-19". Immuno 4, n. 2 (14 maggio 2024): 147–58. http://dx.doi.org/10.3390/immuno4020010.
Park, Hyunjung, Sangjik Lee, Jaehun Lee, Hyuk Moon e Simon Weonsang Ro. "Exploring the JAK/STAT Signaling Pathway in Hepatocellular Carcinoma: Unraveling Signaling Complexity and Therapeutic Implications". International Journal of Molecular Sciences 24, n. 18 (6 settembre 2023): 13764. http://dx.doi.org/10.3390/ijms241813764.
Montero, Paula, Javier Milara, Inés Roger e Julio Cortijo. "Role of JAK/STAT in Interstitial Lung Diseases; Molecular and Cellular Mechanisms". International Journal of Molecular Sciences 22, n. 12 (9 giugno 2021): 6211. http://dx.doi.org/10.3390/ijms22126211.
Damerau, Alexandra, Timo Gaber, Sarah Ohrndorf e Paula Hoff. "JAK/STAT Activation: A General Mechanism for Bone Development, Homeostasis, and Regeneration". International Journal of Molecular Sciences 21, n. 23 (26 novembre 2020): 9004. http://dx.doi.org/10.3390/ijms21239004.
Gouverneur, A., J. Avouac, C. Prati, J. L. Cracowski, T. Schaeverbeke, A. Pariente e M. E. Truchetet. "Inhibiteurs de JAK et risque de cancer". Revue du Rhumatisme 89 (dicembre 2022): A69—A70. http://dx.doi.org/10.1016/j.rhum.2022.10.094.
Neeli, Indira, Zhimin Liu, Nagadhara Dronadula, Z. Alex Ma e Gadiparthi N. Rao. "An Essential Role of the Jak-2/STAT-3/Cytosolic Phospholipase A2Axis in Platelet-derived Growth Factor BB-induced Vascular Smooth Muscle Cell Motility". Journal of Biological Chemistry 279, n. 44 (22 agosto 2004): 46122–28. http://dx.doi.org/10.1074/jbc.m406922200.
Gorissen, Marnix, Erik de Vrieze, Gert Flik e Mark O. Huising. "STAT genes display differential evolutionary rates that correlate with their roles in the endocrine and immune system". Journal of Endocrinology 209, n. 2 (17 febbraio 2011): 175–84. http://dx.doi.org/10.1530/joe-11-0033.
Gerds, Aaron T. "Beyond JAK-STAT: novel therapeutic targets in Ph-negative MPN". Hematology 2019, n. 1 (6 dicembre 2019): 407–14. http://dx.doi.org/10.1182/hematology.2019000048.
Jain, Mayank, Mukul Kumar Singh, Hari Shyam, Archana Mishra, Shailendra Kumar, Ambrish Kumar e Jitendra Kushwaha. "Role of JAK/STAT in the Neuroinflammation and its Association with Neurological Disorders". Annals of Neurosciences 28, n. 3-4 (luglio 2021): 191–200. http://dx.doi.org/10.1177/09727531211070532.
Karati, Dipanjan, Kakasaheb Ramoo Mahadik, Piyush Trivedi e Dileep Kumar. "The Emerging Role of Janus Kinase Inhibitors in the Treatment of Cancer". Current Cancer Drug Targets 22, n. 3 (marzo 2022): 221–33. http://dx.doi.org/10.2174/1568009622666220301105214.
Wahnschaffe, Linus, Till Braun, Sanna Timonen, Anil K. Giri, Alexandra Schrader, Prerana Wagle, Henrikki Almusa et al. "JAK/STAT-Activating Genomic Alterations Are a Hallmark of T-PLL". Cancers 11, n. 12 (21 novembre 2019): 1833. http://dx.doi.org/10.3390/cancers11121833.
Owen, Katie L., Natasha K. Brockwell e Belinda S. Parker. "JAK-STAT Signaling: A Double-Edged Sword of Immune Regulation and Cancer Progression". Cancers 11, n. 12 (12 dicembre 2019): 2002. http://dx.doi.org/10.3390/cancers11122002.
Gutiérrez-Hoya, Adriana, e Isabel Soto-Cruz. "Role of the JAK/STAT Pathway in Cervical Cancer: Its Relationship with HPV E6/E7 Oncoproteins". Cells 9, n. 10 (15 ottobre 2020): 2297. http://dx.doi.org/10.3390/cells9102297.
Pazdrak, K., S. Stafford e R. Alam. "The activation of the Jak-STAT 1 signaling pathway by IL-5 in eosinophils." Journal of Immunology 155, n. 1 (1 luglio 1995): 397–402. http://dx.doi.org/10.4049/jimmunol.155.1.397.
Li, Boheng, Qin Wan, Zhubo Li e Wee-Joo Chng. "Janus Kinase Signaling: Oncogenic Criminal of Lymphoid Cancers". Cancers 13, n. 20 (14 ottobre 2021): 5147. http://dx.doi.org/10.3390/cancers13205147.
Li, Boheng, Qin Wan, Zhubo Li e Wee-Joo Chng. "Janus Kinase Signaling: Oncogenic Criminal of Lymphoid Cancers". Cancers 13, n. 20 (14 ottobre 2021): 5147. http://dx.doi.org/10.3390/cancers13205147.
Serbina, Inessa Mykhailivna, e Yu S. Ovcharenko. "JANUS KINASE INHIBITORS IN DERMATOLOGY: PRESENT AND FUTURE". International Medical Journal, n. 4(108) (10 dicembre 2021): 70–76. http://dx.doi.org/10.37436/2308-5274-2021-4-13.
Moser, Bernhard, Sophie Edtmayer, Agnieszka Witalisz-Siepracka e Dagmar Stoiber. "The Ups and Downs of STAT Inhibition in Acute Myeloid Leukemia". Biomedicines 9, n. 8 (19 agosto 2021): 1051. http://dx.doi.org/10.3390/biomedicines9081051.
Roger, Inés, Javier Milara, Paula Montero e Julio Cortijo. "The Role of JAK/STAT Molecular Pathway in Vascular Remodeling Associated with Pulmonary Hypertension". International Journal of Molecular Sciences 22, n. 9 (7 maggio 2021): 4980. http://dx.doi.org/10.3390/ijms22094980.
Conzelmann, Michael, Elena Rodionova, Michael Hess, Thomas Giese, Anthony D. Ho, Peter Dreger e Thomas Luft. "Complementary JAK/STAT Signalling Is Required for the Pro-Inflammatory Effects of CD40 Ligation: Differential Effects in Human Myeloid and B Cells." Blood 110, n. 11 (16 novembre 2007): 2413. http://dx.doi.org/10.1182/blood.v110.11.2413.2413.
Trivedi, Sunny, e Michelle Starz-Gaiano. "Drosophila Jak/STAT Signaling: Regulation and Relevance in Human Cancer and Metastasis". International Journal of Molecular Sciences 19, n. 12 (14 dicembre 2018): 4056. http://dx.doi.org/10.3390/ijms19124056.
Chen, Pei-Chi, Chen-Hsun Ho, Chia-Kwung Fan, Shih-Ping Liu e Po-Ching Cheng. "Antimicrobial Peptide LCN2 Inhibited Uropathogenic Escherichia coli Infection in Bladder Cells in a High-Glucose Environment through JAK/STAT Signaling Pathway". International Journal of Molecular Sciences 23, n. 24 (12 dicembre 2022): 15763. http://dx.doi.org/10.3390/ijms232415763.
Bonjardim, C. A. "JAK/STAT-deficient cell lines". Brazilian Journal of Medical and Biological Research 31, n. 11 (novembre 1998): 1389–95. http://dx.doi.org/10.1590/s0100-879x1998001100004.
Rabadan, Raul, e Giorgio Inghirami. "JAK-STAT in lymphoproliferative disorders". Oncoscience 2, n. 9 (11 agosto 2015): 737–38. http://dx.doi.org/10.18632/oncoscience.189.
Pernis, Alessandra B., e Paul B. Rothman. "JAK-STAT signaling in asthma". Journal of Clinical Investigation 109, n. 10 (15 maggio 2002): 1279–83. http://dx.doi.org/10.1172/jci0215786.
Barwick, Benjamin G., e Sagar Lonial. "We need CD38 STAT-JAK". Blood 136, n. 20 (12 novembre 2020): 2246–48. http://dx.doi.org/10.1182/blood.2020007467.
Rawlings, J. S. "The JAK/STAT signaling pathway". Journal of Cell Science 117, n. 8 (15 marzo 2004): 1281–83. http://dx.doi.org/10.1242/jcs.00963.
Heinrich, Peter C., Serge Haan, Kevin W. Harris, Heike M. Hermanns, Silke Metz, Gerhard Müller-Newen, Fred Schaper e Monique Wiesinger. "JAK/STAT signaling in cancer". Biomedicine & Pharmacotherapy 60, n. 8 (settembre 2006): 488. http://dx.doi.org/10.1016/j.biopha.2006.07.058.
Villarino, Alejandro V., Massimo Gadina, John J. O’Shea e Yuka Kanno. "SnapShot: Jak-STAT Signaling II". Cell 181, n. 7 (giugno 2020): 1696–1696. http://dx.doi.org/10.1016/j.cell.2020.04.052.
Li, Jiliang. "JAK-STAT and bone metabolism". JAK-STAT 2, n. 3 (15 luglio 2013): e23930. http://dx.doi.org/10.4161/jkst.23930.
Schindler, Christian. "Cytokines and JAK–STAT Signaling". Experimental Cell Research 253, n. 1 (novembre 1999): 7–14. http://dx.doi.org/10.1006/excr.1999.4670.